PRECAINE B CHOCOLATE MINT- benzocaine topical anesthetic gel 
Pascal Company, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Precaine B Chocolate Mint

Directions:

Application Directions:

For topical use only

For best results apply to previously dried oral mucosa with cotton swab or similar applicator for adequate control of pain

Removal of excess saliva during application minimizes dilution of the anesthetic and permits maximum penetration

Not more than 1.2 mg per Kg body weight per patient should be applied during a 24 hour period

Warnings

Warning:

Recommended dosage should not be exceeded due to possible side effects.

Keep out of the reach of children.

For professional use only.

Do not use in the eye.

Avoid swallowing.

Not for home or unsupervised consumer use.

Not for use on children 2 and younger or pregnant or nursing women.

Contraindications

Precaine B is contraindicated in patients with known hypersensitivity to benzocaine or PABA

Other Information:

For product SDS information, please go to www.pascaldental.com or contact Pascal directly.

Store product between 60 degrees F (16 degrees C) and 86 degrees F (30 degrees C).

Rx only is USA

Made in USA

Precaine B

LabelPrecaine B

Topical Anesthetic Gel for Oral Use

Chocolate Mint

Contains: Benzocaine 20% in a flavored aqueous base

Net Contents: 30g

Pascal International

2929 Northup Way

Bellevue, WA 98004

425-827-4694

REF 15-350

SN72507/0217

PRECAINE B CHOCOLATE MINT 
benzocaine topical anesthetic gel
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:10866-0090
Route of AdministrationDENTAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE221 mg  in 1 g
Product Characteristics
ColorgreenScore    
ShapeSize
FlavorCHOCOLATE, MINTImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10866-0090-130 g in 1 JAR; Type 0: Not a Combination Product08/16/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other08/16/2017
Labeler - Pascal Company, Inc. (009260217)
Establishment
NameAddressID/FEIBusiness Operations
Pascal Company, Inc.009260217manufacture(10866-0090)

Revised: 1/2020
Document Id: 9cc137b3-a8fa-1173-e053-2a95a90a7c82
Set id: 5c63ebaf-c26b-2b92-e053-2991aa0a3a21
Version: 2
Effective Time: 20200122
 
Pascal Company, Inc.